 |
| Mark Yarchoan, MD Johns Hopkins University |
This webinar will introduce an upcoming clinical trial at Johns Hopkins, led by Drs. Marina Baretti, Nilo Azad, and Mark Yarchoan.
The trial focuses on a therapeutic vaccine designed to boost the effectiveness of standard immunotherapy drugs for cholangiocarcinoma. Dr. Yarchoan will present information about the vaccine and provide a broader overview of how therapeutic cancer vaccines have evolved.
The discussion will cover past challenges, recent breakthroughs (including successes with vaccines in other types of cancer), and how these advancements could shape future cancer treatments.
Thursday, October 10, 2024
4:00pm (EDT)
No comments:
Post a Comment